Titia G. Meijer

Functional <i>Ex Vivo</i> Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

Titia G. Meijer, Nicole S. Verkaik, Anieta M. Sieuwerts et al. · Clinical Cancer Research · 2018 · 67 citations · Full text

Life Sciences, Genetics, Oncology +16

Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers

Daniel Wetterskog, K-K. Shiu, Irene Chong et al. · Oncogene · 2013 · 52 citations · Full text

Medicine, Molecular Biology, Oncology +14

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests

Titia G. Meijer, Luan Nguyen, Arne van Hoeck et al. · Oncogene · 2022 · 46 citations · Full text

Medicine, Genetics, Oncology +17

Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response

Wenhao Zhang, Wytske M. van Weerden, Corrina M.A. de Ridder et al. · The Prostate · 2018 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +12

Direct Ex Vivo Observation of Homologous Recombination Defect Reversal After DNA-Damaging Chemotherapy in Patients With Metastatic Breast Cancer

Titia G. Meijer, Nicole S. Verkaik, Carolien H. M. van Deurzen et al. · JCO Precision Oncology · 2019 · 24 citations

Medicine, Molecular Biology, Oncology +17